Skip to content

Price / book at other companies

CVS Health logo
CVS HealthCVS
1.2×+0.1×
Amazon logo
AmazonAMZN
5.1×-1.5×
Doximity logo
DoximityDOCS
4.5×-5.5×
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
94.1×+93.1×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
4.1×+2.3×
Cencora logo
CencoraCOR
18×-35.2×

Other financials

Income statement

See full
Revenue$194.0M-4.4%
Gross profit$173.9M-8.3%
Operating income$14.0M-40.1%
Net income$1.2M-89.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$235.7M-21.7%
Total debt$541.4M0.0%
Total equity$622.0M-4.9%
Total assets$2.0B+56.0%

Cash flow

See full
Operating cash flow$11.8M+25.8%
CapEx$1.1M+700%
Free cash flow$10.7M+15.4%

Valuation

See full
Market cap$934.74M-43.1%
Enterprise value$1.24B-34.1%
P/E45.5×-12.3×
P/S1.2×-0.9×

Profitability

See full
Gross margin91.8%-2.0pp
Operating margin9.9%-0.3pp
Net margin2.6%-1.0pp
FCF margin21%+2.3pp

Returns & leverage

See full
Return on equity3.2%-1.2pp
Debt / equity0.9×0.0×
Current ratio1.5×-3.8×

Where this comes from

Calculated from GoodRx Holdings, Inc.’s reported figures.

Based on the most recent quarter.

The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about GoodRx Holdings, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GoodRx Holdings, Inc.'s price / book?
GoodRx Holdings, Inc. (GDRX) reported price / book of 1.1× in Q1 2026.
How has GoodRx Holdings, Inc.'s price / book changed year-over-year?
GoodRx Holdings, Inc.'s price / book decreased by 58.2% year-over-year, from 2.6× to 1.1×.
What is the long-term trend for GoodRx Holdings, Inc.'s price / book?
Over 5 years (2020 to 2025), GoodRx Holdings, Inc.'s price / book has grown at a -42.1% compound annual growth rate (CAGR), from 23× to 1.5×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.